Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance. 		Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist disclosure reporting period:   07/01/2019 - 12/31/2019
Lobbyist name Mary Kaysen   
Business name Bristol-Myers Squibb Company
Address 118 Valley Street   
City, state, zip code Beverly Farms, MA 01915         
Country US
Agent type Both
Phone 978-232-1147
 
 
Operating Expenses
No operating expenses were filed for this disclosure reporting period.
 
Activities, Bill Numbers and Titles
Client: Bristol-Myers Squibb Company
Total amount paid by client; lobbyist is unable to report compensation at activity level: $25,000.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1 making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the Commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements Neutral $0.00 N/A
House Bill 1162 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 541 An Act relative to co-pay assistance Support $0.00 N/A
Senate Bill 703 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 N/A
Senate Bill 2235 An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 898 An Act relative to consumer deductibles Oppose $0.00 N/A
House Bill 1168 An Act establishing a commission to review contracts between pharmaceutical benefit managers and MassHealth Neutral $0.00 N/A
Senate Bill 552 An Act to promote transparency in prescription drug prices Oppose $0.00 N/A
Senate Bill 712 An Act to promote transparency and prevent price gouging of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 2397 An Act relative to pharmaceutical access, costs and transparency Neutral $0.00 N/A
House Bill 1133 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 3877 An Act relative to capping the price of life saving prescription drugs Neutral $0.00 N/A
Senate Bill 683 An Act establishing medicare for all in Massachusetts Oppose $0.00 N/A
Senate Bill 1304 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 N/A
Executive Executive Office of Health and Human Services (EOHHS) Monitoring Executive Office of Health & Human Services implementation 101 CMR 801.00: Drug Manufacturer Negotiations and Accountability Neutral $0.00 N/A
House Bill 1148 An Act regarding Massachusetts drug price relief Oppose $0.00 N/A
Senate Bill 3 An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 695 An Act to improve the accessibility and affordability of pharmaceutical drugs of public health concern Oppose $0.00 N/A
Senate Bill 1352 An Act establishing a special commission to study and recommend improvements in the delivery of prescription drug benefits for the citizens of the Commonwealth Oppose $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring Health Policy Commission implementation 958 CMR 12.00, Drug Pricing Review Neutral $0.00 N/A
House Bill 916 An Act relative to co-pay assistance Support $0.00 N/A
House Bill 1193 An Act providing for the establishment of a drug cost review commission Neutral $0.00 N/A
Senate Bill 570 An Act relative to out-of-pocket expenses for prescription drug coverage Support $0.00 N/A
Senate Bill 721 An Act relative to mandatory prescription drug coverage Oppose $0.00 N/A
House Bill 4246 An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects Neutral $0.00 N/A
House Bill 629 An Act relative to pharmaceutical pricing Oppose $0.00 N/A
House Bill 1167 An Act relative to prescription drug price transparency Oppose $0.00 N/A
Senate Bill 543 An Act reducing health care costs through improved medication management Support $0.00 N/A
Senate Bill 706 An Act to ensure prescription drug cost transparency and affordability Oppose $0.00 N/A
House Bill 4134 An Act to improve health care by investing in VALUE Neutral $0.00 N/A
House Bill 926 An Act relative to consumer deductibles Oppose $0.00 N/A
House Bill 1853 An Act relative to fail first and patient safety Support $0.00 N/A
Senate Bill 582 An Act ensuring access to medications Neutral $0.00 N/A
Senate Bill 728 An Act providing affordable access to generic medicines Neutral $0.00 N/A
House Bill 4127 An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects Neutral $0.00 N/A
House Bill 1013 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
House Bill 3481 An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth Support $0.00 N/A
Senate Bill 646 An Act to strengthen pharmacy benefit management Neutral $0.00 N/A
Senate Bill 1206 An Act to ensure the fair, transparent and patient-focused use of health technology assessments by the Commonwealth Support $0.00 N/A
House Bill 4000 An Act making appropriations for fiscal year 2020 Neutral $0.00 N/A
House Bill 966 An Act to promote value-based insurance design in the Commonwealth Oppose $0.00 N/A
House Bill 1972 An Act to permit the wholesale importation of prescription drugs into the Commonwealth Oppose $0.00 N/A
Senate Bill 640 An Act to ensure access to generic medications Neutral $0.00 N/A
Senate Bill 1149 An Act strengthening prescription drug safety and drug stewardship Oppose $0.00 N/A
Senate Bill 2418 An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects Neutral $0.00 N/A
House Bill 949 An Act relative to non-medical switching Support $0.00 N/A
House Bill 1860 An Act relative to the dispensing of prescription drugs Neutral $0.00 N/A
Senate Bill 601 An Act to reduce the cost of pharmacy benefits Neutral $0.00 N/A
Senate Bill 1218 An Act relative to sharps stewardship Oppose $0.00 N/A
House Bill 4132 An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects Neutral $0.00 N/A
House Bill 915 An Act ensuring access to medications Neutral $0.00 N/A
House Bill 1178 An Act relative to promoting transparency in the pharmaceutical industry Support $0.00 N/A
Senate Bill 561 An Act empowering health care consumers Support $0.00 N/A
Senate Bill 715 An Act relative to pharmaceutical price transparency and cost sharing Neutral $0.00 N/A
Senate Bill 2409 An Act relative to pharmaceutical access, costs and transparency Neutral $0.00 N/A
House Bill 959 An Act requiring continual coverage of prescription medication Neutral $0.00 N/A
House Bill 1930 An Act providing for unused medication return by health care facilities Neutral $0.00 N/A
Senate Bill 611 An Act to promote value-based insurance design in the Commonwealth Oppose $0.00 N/A
Senate Bill 733 An Act relative to consumer protection for prescription drug purchases Support $0.00 N/A
Senate Bill 2378 An Act making appropriations for the fiscal year 2019 to provide for supplementing certain existing appropriations and for certain other activities and projects Neutral $0.00 N/A
House Bill 1016 An Act establishing a commission to study maximum allowable costs lists Neutral $0.00 N/A
House Bill 3551 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 652 An Act relative to pharmaceutical gag clauses Support $0.00 N/A
Senate Bill 1235 An Act relative to step therapy and patient safety Support $0.00 N/A
Senate Bill 2433 An Act relative to step therapy and patient safety Support $0.00 N/A
House Bill 1088 An Act relative to prescription drug access Support $0.00 N/A
House Bill 3800 An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 653 An Act relative to prescription drug pricing Neutral $0.00 N/A
Senate Bill 1295 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 N/A
House Bill 4228 An Act relative to fail first and patient safety Support $0.00 N/A
House Bill 1154 An Act to reduce drug costs through transparency Oppose $0.00 N/A
Senate Bill 159 An Act to protect innovation and entrepreneurship in the Commonwealth Support $0.00 N/A
Senate Bill 696 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 1701 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 N/A
House Bill 1111 An Act allowing for retail pharmacy discounts and co-pay assistance Support $0.00 N/A
House Bill 3801 An Act making appropriations for the fiscal year 2020 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
Senate Bill 654 An Act to strengthen pharmacy benefit management Neutral $0.00 N/A
Senate Bill 1301 An Act to prevent undue influence on prescriber behavior Oppose $0.00 N/A
Executive Massachusetts Health Policy Commission (HPC) Monitoring the Health Policy Commission implementation of Chapter 363 of the Acts of 2018, An Act Extending the Authorization for the use of certain discount vouchers for prescription drugs Neutral $0.00 N/A
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
No meals, travel, or entertainment expenses were filed for this disclosure reporting period.
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateRecipient nameOffice soughtAmount
07/16/2019 The Ferrante Committee House – 5th Essex $200.00
10/21/2019 Committee to Elect Marc McGovern Cambridge City Council $150.00
11/19/2019 Dan Cullinane Committee House – 12th Suffolk $125.00
12/09/2019 Committee to Elect Aaron Michlewitz House – 3rd Suffolk $125.00
  Total contributions $600.00
Close this page
William Francis Galvin Secretary of the Commonwealth of Massachusetts
One Ashburton Place
Boston, MA   02108

1-800-392-6090
cis@sec.state.ma.us

Connect with Us

Terms and Conditions     Accessibility Statement